GlassScriptPhysician profile
Tyler Anderson
NPI 1720240633
$1,537.29
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $429 · 2020: $110 · 2021: $38.74 · 2022: $662 · 2023: $179 · 2024: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $298.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $297.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $687.18 | 2022-2023 | Impella |
| United Therapeutics Corporation | $126.03 | 2023-2024 | Tyvaso |
| Astrazeneca Pharmaceuticals LP | $92.63 | 2019-2023 | Breztri |
| Genzyme Corporation | $83.20 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $49.34 | 2019-2023 | Ofev |
| Mylan Specialty L.P. | $42.18 | 2019-2023 | Yupelri |
| Sunovion Pharmaceuticals INC. | $42.14 | 2019 | |
| Glaxosmithkline, LLC. | $36.55 | 2019 | |
| Insmed, INC. | $34.81 | 2019-2020 | |
| Electromed, INC. | $32.37 | 2019 | |
| Novartis Pharmaceuticals Corporation | $31.95 | 2019 | |
| Advanced Respiratory, INC | $31.71 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $31.28 | 2019-2020 | |
| Abbvie INC. | $23.55 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.23 | 2023 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $20.75 | 2019 | |
| La Jolla Pharmaceutical Company | $17.86 | 2019 | |
| Genentech USA, INC. | $17.39 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.40 | 2020 | |
| Gilead Sciences, INC. | $15.19 | 2021 | |
| Grifols USA, LLC | $14.66 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $14.65 | 2023 | Dupixent |
| Astellas Pharma US INC | $14.15 | 2019 | |
| Philips North America LLC | $13.77 | 2019 | |
| Pulmonx Corporation | $12.96 | 2020 | |
| Allergan, INC. | $12.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.